{"id":"https://genegraph.clinicalgenome.org/r/ce05fc3b-3bbb-4efb-ae61-be05a51e1f4ev1.0","type":"EvidenceStrengthAssertion","dc:description":"*PIK3R5* was first reported in relation to autosomal recessive ataxia-oculomotor apraxia in 2012 in a consanguineous family of which four siblings harbored the same homozygous variant in *PIK3R5* (c.1885C>T, p.P629S) and were affected by ataxia, oculomotor apraxia, sensory axonal neuropathy, progressive distal muscular atrophy, and cerebellar atrophy (Al Tassan *et al.*, PMID: 22065524). However, this variant has a total minor allele frequency of 0.001525 in the general population, is particularly common among the African/African American alleles, with a Grpmax Filtering Allele Frequency of 0.02622, and is observed in thirty homozygotes (Genome Aggregation Database v4.1). To date, no additional *PIK3R5* variants have been reported in relation to autosomal recessive ataxia-oculomotor apraxia. Additional human cases of *PIK3R5*-related ataxia have not been found in the literature. A recent cohort study of 52 patients affected by autosomal recessive cerebellar ataxia with oculomotor apraxia did not detect any variants in *PIK3R5* (PMID: 35426160). This gene-disease relationship is supported by expression studies by Al Tassan *et al.* who demonstrated ubiquitous expression of the PIK3R5 gene in human tissues with high expression in the brain (PMID: 22065524). To date, no publications in scientific literature can be found indicating protein function studies or non-human models showing the ocular motility or coordination and movement deficient phenotype observed in human patients with ataxia-oculomotor apraxia. In summary, the evidence supporting the relationship between *PIK3R5* and autosomal recessive ataxia-oculomotor apraxia has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *PIK3R5* plays in this disease. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date April 9, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ce05fc3b-3bbb-4efb-ae61-be05a51e1f4e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10155","date":"2025-04-10T14:35:10.697Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10155","date":"2025-04-09T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"The allele frequency of the single variant reported in PIK3R5-related autosomal recessive ataxia-oculomotor apraxia is common in the general population, particularly among the African/African-American population, and observed in 30 homozygotes (gnomAD v4.1). No additional patients have been reported since 2012 with PIK3R5-related autosomal recessive ataxia-oculomotor apraxia. No functional studies demonstrating recapitulation of human patient phenotypes in animal models have been reported to date.","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4268b66-f826-40d8-a4f1-49c48097b3dd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/858cd9a6-db78-42a6-872e-48ce6d06cfdc","type":"Finding","dc:description":"Immunohistochemistry on mouse E17 embryos was performed using anti-PIK3R5. PIK3R5 was not expressed in the mouse embryo brain but moderately expressed in hippocampus and\nthalamus of adult mouse brain indicative of stage-specific gene expression. PIK3R5 showed strong and moderate expression in mouse embryonic liver, heart and lung tissues.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065524","rdfs:label":"PIK3R5 expression in murine tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/50798edc-e817-4b85-9763-44399a913e02","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cbb833c-051e-48be-9b24-83edf12d46da","type":"Finding","dc:description":"Amplification of PIK3R5 from different human tissues demonstrated that it is ubiquitously expressed with high expression in fetal brain compared to adult brain, and differential brain expression analysis on cDNA from multiple adult human brain tissues showed abundant expression in cerebellum, cerebral cortex, cerebral meninges, and vermis cerebelli.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065524","rdfs:label":"Expression in brain tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9862f5f-dbf2-4765-8744-03937776d2e9_proband_score_evidence_line","type":"EvidenceLine","direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f293517-bcfe-43ef-9fb7-783aac5fc49e","type":"EvidenceLine","dc:description":"Allele frequency in gnomAD v4.1 is 0.001525 (total); 0.02622 (Grpmax â€“African/African American with 30 homozygotes). gnomAD v3.1 showed 18 African/African American homozygotes.","calculatedScore":0.2,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f293517-bcfe-43ef-9fb7-783aac5fc49e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065524","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4a0de49-5e07-4268-814f-8ec7b272dfeb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001142633.3(PIK3R5):c.1885C>T (p.Pro629Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA143690"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b9862f5f-dbf2-4765-8744-03937776d2e9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065524","rdfs:label":"Proband IV:3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b4a0de49-5e07-4268-814f-8ec7b272dfeb"},"detectionMethod":"Gene sequencing of APTX, MRE11A, SETX with negative results, followed by linkage analysis (chromosome 17 with genes sequenced; MFSD6L, MYH10, NDEL1, NTN1, PIK3R6, and PIK3R5, SPDYE4, STX8) with homozygosity analysis and haplotype testing to confirm segregation of variants.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"distal posterior column sensory loss, impaired ocular movement","phenotypes":["obo:HP_0002317","obo:HP_0002078","obo:HP_0002359","obo:HP_0001350","obo:HP_0000514","obo:HP_0002406"],"previousTesting":true,"previousTestingDescription":"MRI showed cerebellar atrophy","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2f293517-bcfe-43ef-9fb7-783aac5fc49e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9876210c-07d1-48c9-997f-da98db372e14_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06d7e107-43f7-4b63-8d5c-e0685a921977_proband_segregation","type":"FamilyCosegregation","dc:description":"PIK3R5:c.1885C>T variant has total minor allele frequency of 0.001525 in the Genome Aggregation Database (v4.1) and is particularly common among the African/African American alleles (Grpmax Filtering Allele Frequency of 0.02622) with 30 homozygotes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065524","rdfs:label":"Tassan Family","estimatedLodScore":2.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/06d7e107-43f7-4b63-8d5c-e0685a921977","type":"Family","rdfs:label":"Tassan Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b9862f5f-dbf2-4765-8744-03937776d2e9"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"head thrust","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003390","obo:HP_0008955","obo:HP_0000657","obo:HP_0000639","obo:HP_0001272","obo:HP_0001251"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b9862f5f-dbf2-4765-8744-03937776d2e9"},"publishedLodScore":3.38}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Disputed","sequence":10219,"specifiedBy":"GeneValidityCriteria11","strengthScore":1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/zA0YKfxJRGg","type":"GeneValidityProposition","disease":"obo:MONDO_0014084","gene":"hgnc:30035","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9876210c-07d1-48c9-997f-da98db372e14-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}